As of 2025-09-18, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (33.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.47 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -7199.7%.
The range of the Relative Valuation is (32.69) - (32.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.4x - 28.7x | 26.8x |
| Forward P/E multiples | 24.2x - 25.1x | 24.5x |
| Fair Price | (32.69) - (32.33) | (33.10) |
| Upside | -7112.6% - -7035.2% | -7199.7% |
| Date | P/E |
| 2025-09-17 | -0.36 |
| 2025-09-16 | -0.38 |
| 2025-09-15 | -0.34 |
| 2025-09-12 | -0.34 |
| 2025-09-11 | -0.34 |
| 2025-09-10 | -0.35 |
| 2025-09-09 | -0.34 |
| 2025-09-08 | -0.35 |
| 2025-09-05 | -0.37 |
| 2025-09-04 | -0.36 |
| 2025-09-03 | -0.37 |
| 2025-09-02 | -0.38 |
| 2025-08-29 | -0.38 |
| 2025-08-28 | -0.40 |
| 2025-08-27 | -0.41 |
| 2025-08-26 | -0.42 |
| 2025-08-25 | -0.39 |
| 2025-08-22 | -0.38 |
| 2025-08-21 | -0.37 |
| 2025-08-20 | -0.37 |
| 2025-08-19 | -0.38 |
| 2025-08-18 | -0.39 |
| 2025-08-15 | -0.41 |
| 2025-08-14 | -0.38 |
| 2025-08-13 | -0.39 |
| 2025-08-12 | -0.37 |
| 2025-08-11 | -0.37 |
| 2025-08-08 | -0.41 |
| 2025-08-07 | -0.40 |
| 2025-08-06 | -0.39 |
| 2025-08-05 | -0.37 |
| 2025-08-04 | -0.34 |
| 2025-08-01 | -0.34 |
| 2025-07-31 | -0.36 |
| 2025-07-30 | -0.37 |
| 2025-07-29 | -0.39 |
| 2025-07-28 | -0.41 |
| 2025-07-25 | -0.44 |
| 2025-07-24 | -0.44 |
| 2025-07-23 | -0.43 |
| 2025-07-22 | -0.34 |
| 2025-07-21 | -0.35 |
| 2025-07-18 | -0.35 |
| 2025-07-17 | -0.35 |
| 2025-07-16 | -0.31 |
| 2025-07-15 | -0.31 |
| 2025-07-14 | -0.33 |
| 2025-07-11 | -0.34 |
| 2025-07-10 | -0.36 |
| 2025-07-09 | -0.35 |